Cinven buys CRO Medpace for $915m
This article was originally published in Scrip
Executive Summary
CCMP Capital Advisors is to sell the contract research organization Medpace to European private equity firm Cinven for $915m, as investors continue to put their faith and dollars into the clinical service provider market.